Osgep Activators are a diverse array of chemical compounds that indirectly bolster the functional activity of Osgep through their influence on various cellular signaling pathways. Compounds like Forskolin and IBMX, by increasing and sustaining elevated cAMP levels respectively, stimulate PKA, which can phosphorylate proteins and potentially enhance Osgep activity through secondary interactions or signaling cascades. Likewise, PMA, through PKC activation, and Epigallocatechin gallate, as a kinase inhibitor, can modulate cellular processes that indirectly promote Osgep's functional roles within the cell. Specifically, LY294002's inhibition of PI3K and U0126's targeting of MEK1/2 may skew cellular signaling dynamics in a way that favors processes Osgep is involved with, effectively enhancing its activity. Sphingosine-1-phosphate acts on its receptors to initiate downstream signaling that could facilitate Osgep's role in the cell, while Thapsigargin and A23187, by increasing intracellular calcium, activate calcium-dependent kinases and phosphatases, which are known to influence numerous cellular functions including those associated with Osgep.
The array of kinase inhibitors, such as Staurosporine and Genistein, may indirectly enhance Osgep activity by modulating the kinase signaling landscape within the cell, potentially alleviating competitive or regulatory restraints on Osgep's functional pathways. SB203580's specific inhibition of p38 MAP kinase further exemplifies the indirect yet targeted approach these activators take to influence Osgep's activity. By inhibiting certain kinases, these compounds may inadvertently upregulate signaling processes or protein interactions that Osgep is a part of, leading to its enhanced activity without directly increasing its expression or requiring its direct activation. Collectively, these chemical compounds, through their specific actions on distinct cellular signaling pathways, serve to augment the functional activity of Osgep by modulating the complex network of intracellular signals and interactions.
SEE ALSO...
Items 1 to 10 of 11 total
Display:
Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
---|---|---|---|---|---|---|
Forskolin | 66575-29-9 | sc-3562 sc-3562A sc-3562B sc-3562C sc-3562D | 5 mg 50 mg 1 g 2 g 5 g | $76.00 $150.00 $725.00 $1385.00 $2050.00 | 73 | |
Forskolin activates adenylyl cyclase, increasing intracellular cAMP levels. Elevated cAMP activates PKA, which can phosphorylate specific substrates thereby potentially enhancing Osgep activity through secondary modifications. | ||||||
Ionomycin | 56092-82-1 | sc-3592 sc-3592A | 1 mg 5 mg | $76.00 $265.00 | 80 | |
Ionomycin is a calcium ionophore that increases intracellular calcium concentration, potentially enhancing Osgep activity by promoting calcium-dependent signaling pathways in which Osgep might be involved. | ||||||
PMA | 16561-29-8 | sc-3576 sc-3576A sc-3576B sc-3576C sc-3576D | 1 mg 5 mg 10 mg 25 mg 100 mg | $40.00 $129.00 $210.00 $490.00 $929.00 | 119 | |
PMA activates protein kinase C (PKC) which can modulate signaling pathways that may indirectly lead to the activation of Osgep through phosphorylation of proteins that interact with or regulate Osgep function. | ||||||
Isoproterenol Hydrochloride | 51-30-9 | sc-202188 sc-202188A | 100 mg 500 mg | $27.00 $37.00 | 5 | |
Isoproterenol is a beta-adrenergic agonist that elevates cAMP levels, similar to Forskolin, which can indirectly enhance Osgep activity through cAMP-dependent protein kinase signaling pathways. | ||||||
IBMX | 28822-58-4 | sc-201188 sc-201188B sc-201188A | 200 mg 500 mg 1 g | $159.00 $315.00 $598.00 | 34 | |
IBMX is a non-specific inhibitor of phosphodiesterases, which prevents the breakdown of cAMP, potentially enhancing Osgep activity through sustained PKA activation and subsequent phosphorylation events. | ||||||
(−)-Epigallocatechin Gallate | 989-51-5 | sc-200802 sc-200802A sc-200802B sc-200802C sc-200802D sc-200802E | 10 mg 50 mg 100 mg 500 mg 1 g 10 g | $42.00 $72.00 $124.00 $238.00 $520.00 $1234.00 | 11 | |
EGCG is a polyphenol that has been shown to inhibit certain protein kinases, potentially reducing competitive phosphorylation and enhancing pathways that lead to Osgep activation. | ||||||
A23187 | 52665-69-7 | sc-3591 sc-3591B sc-3591A sc-3591C | 1 mg 5 mg 10 mg 25 mg | $54.00 $128.00 $199.00 $311.00 | 23 | |
A23187 is a calcium ionophore that increases intracellular calcium levels, similar to Ionomycin, which can indirectly enhance Osgep activity by activating calcium-dependent signaling pathways. | ||||||
Dibutyryl-cAMP | 16980-89-5 | sc-201567 sc-201567A sc-201567B sc-201567C | 20 mg 100 mg 500 mg 10 g | $45.00 $130.00 $480.00 $4450.00 | 74 | |
db-cAMP is a cell-permeable cAMP analog that activates PKA and can enhance Osgep activity through cAMP-dependent signaling pathways, potentially influencing Osgep regulation. | ||||||
LY 294002 | 154447-36-6 | sc-201426 sc-201426A | 5 mg 25 mg | $121.00 $392.00 | 148 | |
LY294002 is a PI3K inhibitor that can modulate downstream signaling pathways, potentially leading to the enhancement of Osgep activity through indirect effects on cellular processes. | ||||||
PD 98059 | 167869-21-8 | sc-3532 sc-3532A | 1 mg 5 mg | $39.00 $90.00 | 212 | |
PD98059 is an inhibitor of MEK, which may indirectly enhance Osgep activity by modulating MAPK signaling pathways that intersect with regulatory processes of Osgep. |